macular degeneration, macular, diagnosis myopic macular degeneration – My Macular Degeneration Journey/Journal

Myopic Macular Degeneration: Understanding the Basics

by Frank Chen (see his biography at the end of the article).

The prevalence of myopic macular degeneration is on the rise worldwide, and new research is providing greater insight into this complex condition. As our understanding of the condition continues to evolve rapidly, staying up-to-date on the latest developments is crucial — starting from the fundamentals.

Myopic macular degeneration is a debilitating eye condition that affects millions worldwide, leading to a gradual loss of central vision. Like age-related macular degeneration (AMD), myopic macular degeneration affects the central part of the retina, causing symptoms such as blurry vision, distorted vision, and loss of visual acuity.

However, myopic macular degeneration is primarily associated with high myopia and pathologic myopia, which affect people at a younger age than AMD. In this article, we will discuss the key terms and definitions related to myopic macular degeneration, its causes and prevalence, and the treatment options available to manage the condition.

Understanding the Key Terminology of Myopic Macular Degeneration

Myopic macular degeneration is an eye condition that is becoming better understood through ongoing research. As we learn more, terms and definitions evolve or are added to our understanding of this condition. Here are some important terms to know:

Myopia: This is a common refractive error that causes distant objects to appear blurry. It occurs when the eyeball is too long, or the cornea is too curved, causing light to focus in front of the retina instead of on it.

High myopia is a more severe form of myopia, usually defined as more than -6.00 D in diopters. It is often confused with pathologic myopia, which causes degenerative changes in the back of the eye.
Pathologic myopia occurs when the eye grows too long, leading to changes in the back of the eye. These changes can cause problems such as blurry vision, difficulty seeing in low light, and even vision loss.

Myopic Macular Degeneration (MMD) is also called myopic maculopathy (MM); it is one of the most common types of pathologic myopia. It occurs when the cells responsible for sharp, detailed vision in the eye start to die. And patients gradually lose central vision.

Myopic chorioretinal neovascularization (myopic CNV) is also referred to as myopic macular neovascularization (MNV) in many publications. It happens when abnormally new blood vessels grow under the macula. As blood and fluid leak into the macula, it damages the retina cells, which leads to vision loss.

Causes and Prevalence of Myopic Macular Degeneration

Myopic macular degeneration is a condition that affects the central part of the retina, known as the macula, and causes it to degenerate. This can result in symptoms such as blurry or distorted vision, dark or empty areas in the field of vision, and a gradual loss of visual acuity over time, similar to age-related macular degeneration (AMD).

The exact cause of myopic macular degeneration is unclear, but several factors are believed to contribute to its development. These factors include elongation of the eye, cracks in the retina, and protrusion or bulging of the back part of the eye (myopic conus).

As myopia is becoming increasingly common worldwide, studies found a rise in the prevalence of myopic macular degeneration. It was projected that by 2050, around 50% of the global population could have myopia.

Furthermore, the risk of developing pathologic myopia, which could lead to myopic macular degeneration, increased with higher degrees of myopia. Age was also a significant factor, as individuals with high myopia aged 40 or older had a higher risk of developing pathologic myopia.

Studies showed that pathologic myopia affected approximately 1-3% of Asians and 1% of Caucasians. Pathologic myopia was identified to be the leading cause of irreversible blindness in several Asian countries. While in Western countries, it ranked as the third leading cause of blindness. Both ethnicity and country of origin seemed to play a role.

Treatment for Myopic Chorioretinal Neovascularization (Myopic CNV)

Several treatment options are available that can help slow the progression of myopic chorioretinal neovascularization (myopic CNV) and improve vision. The primary treatment for myopic CNV is anti-VEGF therapy, which includes several different drugs like ranibizumab (Lucentis), aflibercept (Eylea), and conbercept (Lumitin). Although bevacizumab (Avastin) is not FDA-approved for myopic CNV, it may still be used as an off-label treatment due to cost.

In cases where anti-VEGF therapy is not suitable, verteporfin photodynamic therapy (vPDT) may be recommended. However, vPDT didn’t show significant improvement in visual acuity and could damage the retina cells, leading to a worsening of vision instead. Therefore, intravitreal anti-VEGF therapy is considered the standard-of-care treatment for myopic CNV. As with any treatment, there are benefits and risks. Therefore, it is important to discuss treatment options with your healthcare provider to find the most effective and appropriate treatment for your specific situation if you have myopic CNV.

Key Takeaways

In conclusion, myopic macular degeneration is a serious eye condition that affects millions worldwide, leading to a gradual loss of their vision. While it shares similarities with age-related macular degeneration, myopic macular degeneration is primarily associated with high myopia and pathologic myopia, which affect people at a younger age. With the rise in myopia prevalence worldwide, understanding the latest development, starting from the fundamentals, is essential.

Fortunately, there are treatment options available for myopic chorioretinal neovascularization. And it is fueled by ongoing research and innovation, providing hope for a bright future for people living with this condition.

About the Author

Frank Chen is a highly experienced health educator and medical writer with almost two decades of experience in the healthcare and pharmaceutical industries. He holds a Bachelor of Science degree and an MBA, and is also certified in nutritional sciences and medical writing, bringing a broad range of knowledge to his work. Frank is deeply committed to enhancing patient health literacy and promoting better patient outcomes. His passion for helping patients understand their health conditions is evident in his exemplary education work for ocular conditions at clearsightcorner.com.

Frank has collaborated with top medical experts in ophthalmology, diabetes, and cardiovascular fields throughout the years. He has also played vital roles in developing and implementing patient communication or support projects that have had a profound positive impact on the lives of hundreds of thousands of patients across multiple countries.

Article published Feb. 25th, 2023.

Back: Guest Author Pages

 

What is Myopic Macular Degeneration?

Question: What is Myopic Macular Degeneration which is also called MMD?

Top of diagram shows normal eye & vision. Below, myopic eye and vision.

Myopic Macular Degeneration (MMD) occurs in some people who are severely shortsighted/nearsighted/myopic. In early myopia, which is very common, the shape of the eye changes from that of a baseball to that of a football. When that happens, the distance from the front of the eye to the retina in the back is longer which can cause problems focusing. At that stage, eyeglasses can help.

When it is severe, the elongation of the eye thins all areas of the retina including the macula. This thinning can cause retinal cells to atrophy which leads to loss of central vision. Severe myopia is called high myopia which can become pathological myopia. If it includes the macula, it’s called Myopic Macular Degeneration, MMD, Myopic MD, Myopic Maculopathy, or degenerative myopia. Many of these terms are used interchangeably.

Potential Problems from Pathological Myopia

The thinning affects the entire retina and can cause retinal tears, retinal detachment, cataracts, and glaucoma.

Myopic Macular Degeneration – CNV

Sometimes the thinning of the retina causes new, unwanted blood vessels to grow from the choroid (normal blood supply to the retina) to the area of the photoreceptors which give us sight. This is called CNV or Myopic CNV or Myopic Choroidal Neovascularization (that’s what CNV means). These new blood vessels are fragile and can leak blood or fluid.  It’s what happens in wet AMD and is sometimes called wet MMD.

You can find out more in the articles Myopic Macular Degeneration and What is Myopic Macular Degeneration?

MMD and AMD

Similarities
Where they are different is the cause:
    • MMD is caused by the action of the eyeball changing from an oval shape to a football shape. That ‘mechanical’ action causes the retina to thin including the area of the macula.
    • AMD is caused by some things we know (genes, age, lifestyle) but some things we don’t know yet.

Treatment

In MMD, AMD, diabetic retinopathy, other types of macular degeneration, when there is a build up of a protein called VEGF, the tiny blood vessels below the macula start to grow toward the RPEs & photorecepters which are both necessary for vision. VEGF is actually a good thing elsewhere in the body because it promotes healing. Not in the retina. This process is called CNV for Choroidal NeoVascularization
and can occur in any form of MD and other retinal diseases. CNV is treated with anti-VEGF injections. 
The word ‘wet’ – some people call CNV in MMD ‘wet’ MMD. In medical language, dry AMD is atrophic and wet is neovascular or exudative. Atrophic means ‘atrophied’ or ’tissue that has atrophied.’ Exudative refers to ‘exudate’ which is the fluid or blood that comes out of blood vessels. It’s because of the exudate/fluid/blood that the term wet AMD or wet MMD is used.

Supplements

The AREDS2-based supplements have not been tested in those with MMD because of the differences in causes. AMD is a disease process, whereas MMD is from a mechanical change in the shape of the eyeball.
Some people with MMD take lutein & zeaxanthin supplements and eat foods high in them because they build up the pigment in the macula which is thinned in MMD. I cannot, however, find any research to prove that this is of benefit.

Living and Thriving with MMD

Here is an interview with Dr. Bonnielin Swenor, from Wilmer Eye Institute at Johns Hopkins whose diagnosis of and journey with Myopic Macular Degeneration led her to her current position at Wilmer as Director of the Johns Hopkins University Disability Health Research Center and Associate Professor of Ophthalmology.

Research

The area of research of the most interest to those with vision loss from any ocular disease is that of stem cells being used to replace failing or dead retina cells. Most of the current research is focused on those with AMD because there are more people with AMD than MMD.

The best way to keep updated on all MMD research is to join the Facebook group ‘Myopic Macular Degeneration : Patients For a Cure’ (link is below). They are actively monitoring all research that is about MMD or could be applied to MMD especially that using stem cells. They were able to set up an online discussion with Professor Pete Coffey of the London Project to Cure Blindness. This is the video recording of that discussion: ‘Myopic macular degeneration and how to find a cure.’

Facebook Groups

If you have MMD, I welcome you to join our Facebook group where you can learn about the disease and how to manage your life with a visual impairment (if you have one). Most of our members do have AMD, but we have members with MMD as well. There are other groups specific to MMD (I don’t belong to the first one list, but I do belong to the second one):


go back to frequently asked questions

 

MYopia, My Journey: Part 3 Advocate for Yourself

Advocate for Yourself by Andrea Junge

Retina specialists are obviously very intelligent. Very intelligent and very busy. Every time I go in, the waiting room is FILLED with people. Personally, I’ve had experience with two retina specialists, and I think it’s important to tell you about both.

Both are very intelligent men doing a very important job. Aside from doctors helping cure terminal illnesses, what could be more important than helping people preserve their vision? Both specialists knew, medically, what to say to me. Both gave a diagnosis, listed reasons to come back (flashing lights, curtain coming in from any side of the eye, black pepper spots…), provided suggestions for supplement, and delivered the news of no cure.

The difference between the two specialists is empathy. I’m admittedly very emotional at the specialist office. How could I not be? All of the doctors rush in to look at my eyes because I’m so young. They mistakenly think I’m the patient’s daughter (my mom always accompanies me to these visits), and when I look around, I think why am I here? I’m too young for this.

The first specialist didn’t have great bedside manner, and I was okay with that until I went in to see him one time because of a noticeable increase of flashing lights: taking off work, and paying yet another $50 copay…and instead of dilating me and looking into my eyes, he simply told me that my eyes were fine, that I was worrying too much (he was right about that!), and that I needed antidepressants (wrong!). New specialist coming right up!

When I went to visit my second and current specialist, I could tell he cared how I felt, and that is so comforting. He still cannot cure me, but he makes me feel calm. Long story short, he found a tear in my retina (the tear my original specialist may have found if he dilated me instead of trying to prescribe antidepressants).

Always advocate for yourself.

Every time I leave the retina specialist’s office, I leave with questions and wonder. I ask questions while I’m there like, “Is running safe for my eyes?” Both specialists told me not to stop running, exercise is healthy for your eyes, right? Well, neither specialists are runners (I asked), and they can’t possibly understand the constant pounding of the eyes with every step I took. I stopped running anyway.

Always advocate for yourself.

Both specialists suggested Preservision AREDS2 [Lin/Linda: please read the Caution below], but neither told me that a certain percent of the population who takes this supplement is at risk for zinc actually HARMING their eyes. I researched this myself and good thing I did, because I’m in that certain percent (lucky me…). In fact, my awesome, empathetic specialist told me NOT to have the genetic testing done and suggested I buy Christmas gifts with saved money instead. (wrong!).

Always advocate for yourself.

Two months ago, I was a runner who took too much zinc, with a tear in my retina. Now, I’m a walker who doesn’t take zinc, with a fixed retina…because I always advocate for myself.

One other thing I learned by researching myself is that I will not ever be completely blind as I had envisioned when I was first diagnosed. Nobody wants to lose their central vision, but doesn’t that seem a whole lot better than going blackout blind? Shouldn’t one of my retinal specialists explained this to me?

Always advocate for yourself.

Contact information for ArcticDx the company that did the genetic testing

If you are on the fence about getting the genetic testing done, I can tell you that I am so glad and proud of myself that I did. Knowledge is such a powerful tool, sometimes our only tool. Just think…if I didn’t have the genetic testing done, I’d still be taking zinc and harming my eyes instead of helping them. That’s devastating.

[Lin/Linda here: click on the image to the left to go to the webpage for ArcticDX, the company that did Andrea’s genetic testing].

Caution

Neither the AREDS nor AREDS2 supplements were tested with those with Myopic Macular Degeneration for safety and effectiveness. These are high doses of vitamins and minerals and without research with this particular type of macular degeneration, we feel that taking them is not advisable.  Since MMD affects people at younger ages than AMD, taking these supplements over a LONG period of time could do harm…we just don’t know. Andrea was right in doing her research. Regarding the effect of high doses of zinc on MMD, we don’t know if the same risks apply.  Andrea was smart to do her research on that as well.

 

Continue reading “MYopia, My Journey: Part 3 Advocate for Yourself”

MYopia, My Journey: Part 2 The Joy Thief

The Joy Thief by Andrea Junge

Myopic Macular Degeneration is stealing my joy.

I recently stopped running, something I loved so much, because the pounding posed threat to my fragile retina.

Joy stolen.

I am blessed to have a wonderful loving and supportive husband, am raising two beautiful and healthy sons age 8 and 5, I have amazing and supportive parents, caring friends and coworkers…and am still struggling with the dark visions of my future…even though my ‘now’ is really, really great.

Joy stolen.

I’m struggling. Big time. I cry a lot. I pray a lot. I complain a lot. I research a lot. I feel sorry for myself a lot.

Joy stolen.

The only thing that makes me feel any better right now is knowledge.

Knowledge and what I choose to fuel my body with each and every day gives me a strange sense of power. I am researching and learning everything I can about eye health, nutrition and supplement. I eat spinach and arugula (gross! Seriously, it’s not good), orange bell peppers, and blueberries EVERY.SINGLE.DAY.

Joy stolen.

I am a work in progress. I’m learning that, for me, this is a grieving process. I’m grieving the loss of my vision before I’ve even lost it. I’m grieving the changes to the future I had planned for myself before these plans have had a chance to come to fruition.

Joy stolen.

Recently, my eyes started showing me just how ‘sick’ they are. A few months ago, I had to have laser surgery to repair a tear in my retina and my blind spot seems so big. I have a bazillion floaters and flashing lights and any slight change rushes me into the overcrowded specialist office that is filled with people more than twice my age. I cry every single time I’m there, but I am gratefully still able to live a pretty normal life. I can still work, drive and read. I can still see my children’s beautiful faces. Yet I’m sad because I feel like I’m losing the battle.

Joy stolen.

I have oodles of sunglasses, technology glasses for myself and my children. I know which supplements I should take and which supplements they should take. Sometimes more than myself, I worry about my children. Will they have this disease? How can I help them now? Is Evan wearing his sunglasses? Did Wyatt swallow his vitamins or hide them?

Joy stolen.

I’m having to relearn who I am and what I will and won’t allow for myself. I don’t know all of the answers to my problem, but I do know that my worrying will inevitably become regret someday if I allow it to continue to rob me of the joys in life that I love so much.

It’s a new year and my resolution is to stop this joy thief.

Continue reading “MYopia, My Journey: Part 2 The Joy Thief”

MYopia, My Journey: Part 1 MYopia

MYopia by Andrea Junge

At the mere age of 26, I was driving to work and thought, hmmm…

I was seeing what I didn’t know at the time was my very first blind spot. I was 8 weeks pregnant with my first child and assumed it was some kind of weird pregnancy symptom. It had to be, right? Unfortunately, it was the beginning of what I now know is myopic macular degeneration, probable central blindness, a different future than I had planned – much earlier than feels fair.

Myopic Macular Degeneration basically mimics AMD, only much sooner in life. It is a fairly new diagnosis with no cure.

I have always been extremely myopic. I got my first pair of coke bottle glasses at 5 and I was okay with it…until that first blind spot reared its ugly head and I learned the extent of my extreme myopia and what that really meant. Right away, I started grieving the future I had planned for myself and for my growing family. Everything I envisioned for my future turned into these scary mental images of me sitting in bed crying, in the dark, alone.

As time went on, there wasn’t any noticeable change to my eyes. For almost 8 years, I had so little change that I didn’t even think about it much anymore, and my miraculous brain had even hidden my blind spot! My family grew, life went on and then BOOM! In May of 2016, as I was reading to my students, I noticed my blind spot again and realized it was bigger. My heart sunk into my stomach. I knew this was not good.

My name is Andrea Junge, I am 34 years old, and am losing my vision. That’s not easy to admit. The last 7 months have been filled with specialist visits, surgeries, tests, research, education and a lot of worry and anxiety.

I am a very sentimental person. Every memory my family makes is documented with a picture so I can relive it all whenever I want. I am that mom who holds onto her young children for dear life because watching them grow up is amazing and hard all at the same time. I am a planner by nature, and this disease is not something I planned for. I am truly grateful for every day I wake up and can see, but I am so scared.

Losing your vision is frightening. There is so much unknown. I think about it all the time. I worry all the time.

written January 2017


Andrea Junge is 34 and has extreme myopia. She has struggled with vision her whole life, but was recently diagnosed with myopic macular degeneration. She and her husband, Chris, are raising two young boys who love to play soccer and video games, explore nature, snuggle with the family’s two dogs: a dachshund and a pitbull, and play board games as a family. Last summer, the Junge family moved to the small town where Andrea has taught third grade for 13 years. She is lucky enough to bring her sons to school with her every day, where they are taught by her supportive coworkers and friends. Andrea enjoys nothing more than being a mom and strives every day to be a loving wife and caring teacher, while learning how to maintain a healthy lifestyle in attempt to preserve her vision. Andrea is an early riser. She wakes well before everyone else in her family to get outside and exercise, all year long. Fresh air helps Andrea clear her head and start her day in a healthy, positive way.

Continue reading “MYopia, My Journey: Part 1 MYopia”

Welcome!

June 2023 There’s an announcement that since Sue has not written any new journal pages for some time, the site has been archived until we can decide if the work necessary to make sure all information is accurate and up-to-date can be made. In the meantime, you’ll get some pages ‘not found’ or ‘private’ until that decision has been made. The emphasis for several years has been on the Facebook group.

You are here to follow the journey & misadventures of a woman named Sue who became visually impaired with Age-Related Macular Degeneration (AMD or ARMD) seemingly overnight.   Join in the tears and laughter. Join in the discussion. Learn more about Age-Related Macular Degeneration. Find resources for your own journey or that of someone you know.

We’re going on a bear hunt….can’t go over it, can’t go under it, got to go through it.

Sue is a psychologist trained in Dialectic Behavior Therapy (DBT) and is using it to help her cope with this vision loss. Her trusted and invaluable friends bring computer, research and occupational therapy skills to this endeavor. Yeah team! We hope you benefit from the fruits of our labors.

We are not offering free psychological therapy.  We are not medical people.   Please read the disclaimer.

This website is divided into 4 parts:

  1. If you have just been diagnosed or if you are beginning your research, here’s a place to start in I Have Macular Degeneration…Now What?
  2. Sue’s journal pages which are like chapters in a book
  3. Highlights & News which are basically blog posts
  4. Links to helpful resources (still under construction)

For those of you who aren’t familiar with websites or blogs like this, to ensure that you will be notified when information is added to the website, you must subscribe by email.  On a laptop & most tablets, you’ll find the place where you can do this in the right-hand column.  On a smart phone, you will find it below the content for the page that you are looking at.

We are still learning, we don’t know everything about this challenging disease.

Courses Coming Soon!

Thanks!

Thanks to Lesley B., Sally R., Dave M. and Gerry M. for going through the website looking for links that didn’t work, things that didn’t read well and typos.  We couldn’t have done it without you.